Cited by 202Liver physiology and pathologyWnt/β-catenin signaling in development and cancerDevelopmental Biology and Gene Regulation

β-Catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development

Open access
Tan, Xinping, Yuan, Youzhong, Zeng, Gang, Apte, Udayan, Thompson, Michael D., Cieply, Benjamin, Stolz, Donna B., Michalopoulos, George K. +2 more·2008·Hepatology

Abstract

β-Catenin, the central component of the canonical Wnt pathway, plays important roles in the processes of liver regeneration, growth, and cancer. Previously, we identified temporal expression of β-catenin during liver development. Here, we characterize the hepatic phenotype, resulting from the successful deletion of β-catenin in the developing hepatoblasts utilizing Foxa3-cyclization recombination and floxed -β-catenin (exons 2 through 6) transgenic mice. β-Catenin loss in developing livers resulted in significantly underdeveloped livers after embryonic day 12 (E12) with lethality occurring at around E17 stages. Histology revealed an overall deficient hepatocyte compartment due to (1) increased cell death due to oxidative stress and apoptosis, and (2) diminished expansion secondary to decreased cyclin-D1 and impaired proliferation. Also, the remnant hepatocytes demonstrated an immature phenotype as indicated by high nuclear to cytoplasmic ratio, poor cell polarity, absent glycogen, and decreased expression of key liver-enriched transcription factors: CCAAT-enhancer binding protein-α and hepatocyte nuclear factor-4α. A paucity of primitive bile ducts was also observed. While the stem cell assays demonstrated no intrinsic defect in hematopoiesis, distorted hepatic architecture and deficient hepatocyte compartments resulted in defective endothelial cell organization leading to overall fetal pallor. Conclusion: β-Catenin regulates multiple, critical events during the process of hepatic morphogenesis, including hepatoblast maturation, expansion, and survival, making it indispensable to survival.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.22225

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GSTMs are glutathione S-transferase family members within the mu subfamily that are activated upon WNT and NRF2 signaling.

    “GSTMs are glutathione S-transferase family members within the mu subfamily that are activated upon WNT and NRF2 signaling (40–43).”

    From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [42]

    The Results report that GST-mu1 expression decreased in β-catenin-deficient fetal mouse livers, supporting an association with Wnt/β-catenin signaling in that setting. The paper does not establish that Wnt directly activates GSTMs, and the passages found do not address NRF2 signaling. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. [1]Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. Lack of beta-catenin affects mouse development at gastrulation. Development. 1995;121:3529–3537. doi: 10.1242/dev.121.11.3529. [DOI] [PubMed] [Google Scholar] · DOI
  2. [2]Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science. 2000;287:1606–1609. doi: 10.1126/science.287.5458.1606. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  3. [3]Morin PJ. beta-Catenin signaling and cancer. Bioessays. 1999;21:1021–1030. doi: 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar] · DOI
  4. [4]Pennisi E. How a growth control path takes a wrong turn to cancer. Science. 1998;281:1438–1439. doi: 10.1126/science.281.5382.1438. News; Comment. erratum appears in Science 1998;281:1809. [DOI] [PubMed] [Google Scholar] · DOI
  5. [5]Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res. 2000;77:1–24. doi: 10.1016/s0065-230x(08)60783-6. [DOI] [PubMed] [Google Scholar] · DOI
  6. [6]de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A. 1998;95:8847–8851. doi: 10.1073/pnas.95.15.8847. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  7. [7]Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–524. doi: 10.1002/hep.21068. [DOI] [PubMed] [Google Scholar] · DOI
  8. [8]Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology. 2001;33:1098–1109. doi: 10.1053/jhep.2001.23786. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  9. [9]Sodhi D, Micsenyi A, Bowen WC, Monga DK, Talavera JC, Monga SP. Morpholino oligonucleotide-triggered beta-catenin knockdown compromises normal liver regeneration. J Hepatol. 2005;43:132–141. doi: 10.1016/j.jhep.2005.02.019. [DOI] [PubMed] [Google Scholar] · DOI
  10. [10]Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, et al. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology. 2005;129:285–302. doi: 10.1053/j.gastro.2005.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  11. [11]Sekine S, Gutierrez PJ, Lan BY, Feng S, Hebrok M. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology. 2007;45:361–368. doi: 10.1002/hep.21523. [DOI] [PubMed] [Google Scholar] · DOI
  12. [12]Sekine S, Lan BY, Bedolli M, Feng S, Hebrok M. Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology. 2006;43:817–825. doi: 10.1002/hep.21131. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  13. [13]Hussain SZ, Sneddon T, Tan X, Micsenyi A, Michalopoulos GK, Monga SP. Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res. 2004;292:157–169. doi: 10.1016/j.yexcr.2003.08.020. [DOI] [PubMed] [Google Scholar] · DOI
  14. [14]Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK, Monga SP. Beta-catenin is temporally regulated during normal liver development. Gastroenterology. 2004;126:1134–1146. doi: 10.1053/j.gastro.2003.12.047. [DOI] [PubMed] [Google Scholar] · DOI
  15. [15]Monga SP, Monga HK, Tan X, Mule K, Pediaditakis P, Michalopoulos GK. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology. 2003;124:202–216. doi: 10.1053/gast.2003.50000. [DOI] [PubMed] [Google Scholar] · DOI
  16. [16]Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 2001;128:1253–1264. doi: 10.1242/dev.128.8.1253. [DOI] [PubMed] [Google Scholar] · DOI
  17. [17]Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, et al. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology. 2006;44:992–1002. doi: 10.1002/hep.21317. [DOI] [PubMed] [Google Scholar] · DOI
  18. [18]Postic C, Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis. 2000;26:149–150. doi: 10.1002/(sici)1526-968x(200002)26:2<149::aid-gene16>3.0.co;2-v. [DOI] [PubMed] [Google Scholar] · DOI
  19. [19]Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology. 2006;131:1561–1572. doi: 10.1053/j.gastro.2006.08.042. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  20. [20]Lee CS, Friedman JR, Fulmer JT, Kaestner KH. The initiation of liver development is dependent on Foxa transcription factors. Nature. 2005;435:944–947. doi: 10.1038/nature03649. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  21. [21]Monga SP, Hout MS, Baun MJ, Micsenyi A, Muller P, Tummalapalli L, et al. Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol. 2005;167:1279–1292. doi: 10.1016/S0002-9440(10)61215-1. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  22. [22]Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. AmJ Pathol. 2003;163:1301–1311. doi: 10.1016/S0002-9440(10)63489-X. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  23. [23]Gallagher EP, Gardner JL, Barber DS. Several glutathione S-transferase isozymes that protect against oxidative injury are expressed in human liver mitochondria. Biochem Pharmacol. 2006;71:1619–1628. doi: 10.1016/j.bcp.2006.02.018. [DOI] [PubMed] [Google Scholar] · DOI
  24. [24]Knight TR, Choudhuri S, Klaassen CD. Constitutive mRNA expression of various glutathione s-transferase isoforms in different tissues of mice. Toxicol Sci. 2007;100:513–524. doi: 10.1093/toxsci/kfm233. [DOI] [PubMed] [Google Scholar] · DOI
  25. [25]Ovejero C, Cavard C, Perianin A, Hakvoort T, Vermeulen J, Godard C, et al. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology. 2004;40:167–176. doi: 10.1002/hep.20286. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  26. [26]Cadoret A, Ovejero C, Terris B, Souil E, Levy L, Lamers WH, et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene. 2002;21:8293–8301. doi: 10.1038/sj.onc.1206118. [DOI] [PubMed] [Google Scholar] · DOI
  27. [27]Loeppen S, Koehle C, Buchmann A, Schwarz M. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis. 2005;26:239–248. doi: 10.1093/carcin/bgh298. [DOI] [PubMed] [Google Scholar] · DOI
  28. [28]Darlington GJ, Wang N, Hanson RW. C/EBP alpha: a critical regulator of genes governing integrative metabolic processes. Curr Opin Genet Dev. 1995;5:565–570. doi: 10.1016/0959-437x(95)80024-7. [DOI] [PubMed] [Google Scholar] · DOI
  29. [29]Dinic S, Bogojevic D, Petrovic M, Poznanovic G, Ivanovic-Matic S, Mihailovic M. C/EBP alpha and C/EBP beta regulate haptoglobin gene expression during rat liver development and the acute-phase response. Mol Biol Rep. 2005;32:141–147. doi: 10.1007/s11033-005-0750-0. [DOI] [PubMed] [Google Scholar] · DOI
  30. [30]Zannis VI, Kan HY, Kritis A, Zanni E, Kardassis D. Transcriptional regulation of the human apolipoprotein genes. Front Biosci. 2001;6:D456–D504. doi: 10.2741/zannis. [DOI] [PubMed] [Google Scholar] · DOI
  31. [31]Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, et al. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003;34:292–296. doi: 10.1038/ng1175. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  32. [32]Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, et al. Apc tumor suppressor gene is the “zonation-keeper” of mouse liver. Dev Cell. 2006;10:759–770. doi: 10.1016/j.devcel.2006.03.015. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  33. [33]Suksaweang S, Lin CM, Jiang TX, Hughes MW, Widelitz RB, Chuong CM. Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation. Dev Biol. 2004;266:109–122. doi: 10.1016/j.ydbio.2003.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  34. [34]McLin VA, Rankin SA, Zorn AM. Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development. 2007;134:2207–2217. doi: 10.1242/dev.001230. [DOI] [PubMed] [Google Scholar] · DOI
  35. [35]Ober EA, Verkade H, Field HA, Stainier DY. Mesodermal Wnt2b signalling positively regulates liver specification. Nature. 2006;442:688–691. doi: 10.1038/nature04888. [DOI] [PubMed] [Google Scholar] · DOI
  36. [36]Lemaigre F, Zaret KS. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev. 2004;14:582–590. doi: 10.1016/j.gde.2004.08.004. [DOI] [PubMed] [Google Scholar] · DOI
  37. [37]Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426. doi: 10.1038/18884. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  38. [38]Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology. 2008;47:288–295. doi: 10.1002/hep.21973. [DOI] [PubMed] [Google Scholar] · DOI
  39. [40]Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, et al. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 2007;133:1579–1591. doi: 10.1053/j.gastro.2007.08.036. [DOI] [PubMed] [Google Scholar] · DOI
  40. [41]Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol. 1996;132:1133–1149. doi: 10.1083/jcb.132.6.1133. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  41. [42]Spath GF, Weiss MC. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol. 1998;140:935–946. doi: 10.1083/jcb.140.4.935. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  42. [43]Gomez-Lechon MJ, Jover R, Donato T, Ponsoda X, Rodriguez C, Stenzel KG, et al. Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. J Cell Physiol. 1998;177:553–562. doi: 10.1002/(SICI)1097-4652(199812)177:4<553::AID-JCP6>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar] · DOI
  43. [44]Paulson KE, Darnell JE, Jr, Rushmore T, Pickett CB. Analysis of the upstream elements of the xenobiotic compound-inducible and positionally regulated glutathione S-transferase Ya gene. Mol Cell Biol. 1990;10:1841–1852. doi: 10.1128/mcb.10.5.1841-1852.1990. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  44. [45]Romero L, Higgins MA, Gilmore J, Boudreau K, Maslen A, Barker HJ, et al. Down-regulation of alpha class glutathione S-transferase by interleukin-1beta in human intestinal epithelial cells (Caco-2) in culture. Drug Metab Dispos. 2002;30:1186–1193. doi: 10.1124/dmd.30.11.1186. [DOI] [PubMed] [Google Scholar] · DOI
  45. [46]Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 1996;10:804–815. doi: 10.1101/gad.10.7.804. [DOI] [PubMed] [Google Scholar] · DOI
  46. [47]Matsui T, Kinoshita T, Morikawa Y, Tohya K, Katsuki M, Ito Y, et al. K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J. 2002;21:1021–1030. doi: 10.1093/emboj/21.5.1021. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  47. [48]Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A. beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation. Cell Tissue Res. 2006;323:71–79. doi: 10.1007/s00441-005-0045-8. [DOI] [PubMed] [Google Scholar] · DOI
  48. [49]Gallicano GI, Bauer C, Fuchs E. Rescuing desmoplakin function in extra-embryonic ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and vasculature. Development. 2001;128:929–941. doi: 10.1242/dev.128.6.929. [DOI] [PubMed] [Google Scholar] · DOI
  49. [50]Zhou J, Qu J, Yi XP, Graber K, Huber L, Wang X, et al. Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. Am J Physiol Heart Circ Physiol. 2007;292:H270–H276. doi: 10.1152/ajpheart.00576.2006. [DOI] [PubMed] [Google Scholar] · DOI
  50. [51]Solanas G, Miravet S, Casagolda D, Castano J, Raurell I, Corrionero A, et al. beta-Catenin and plakoglobin N- and C-tails determine ligand specificity. J Biol Chem. 2004;279:49849–49856. doi: 10.1074/jbc.M408685200. [DOI] [PubMed] [Google Scholar] · DOI
  51. [52]Kinoshita T, Sekiguchi T, Xu MJ, Ito Y, Kamiya A, Tsuji K, et al. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A. 1999;96:7265–7270. doi: 10.1073/pnas.96.13.7265. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Tan, X., Yuan, Y., Zeng, G., Apte, U., Thompson, M. D., Cieply, B., Stolz, D. B., Michalopoulos, G. K., Kaestner, K. H., & Monga, S. P. S.
Affiliations
University of Pennsylvania (US)
Corresponding author
Monga, Satdarshan P.S.
Venue
Hepatology
Published
2008-05
Volume
47
Issue
5
Pages
1667-1679
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2055373965
Cited by
202
References
1
Citations by year
2026: 4 · 2025: 4 · 2024: 10 · 2023: 4 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 13 · 2016: 16 · 2015: 18 · 2014: 5 · 2013: 13 · 2012: 16
FWCI
14.43
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (NIH) (1R01DK62277, R01CA124414)
  • Rango's Fund for Enhancement of Pathology Research; and the Cleveland Foundation
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
β-catenin, hepatoblasts, liver development, Wnt/β-catenin signaling, hepatocyte maturation, hepatocyte proliferation, apoptosis, oxidative stress, cyclin D1, C/EBPα, HNF4α, bile ducts, embryonic lethality
MeSH terms
alpha-Fetoproteins, Animals, Liver, Morphogenesis, RNA, Serum Albumin, Gene Deletion, Mice, Knockout, Gene Expression Regulation, Developmental, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, beta Catenin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review